Sprynski, A. C., Hose, D., Kassambara, A., Vincent, L., Jourdan, M., Rossi, J. F., . . . Klein, B. (2010). Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. Leukemia, 24(11), . https://doi.org/10.1038/leu.2010.192
Chicago-Zitierstil (17. Ausg.)Sprynski, A. C., Dirk Hose, A. Kassambara, L. Vincent, M. Jourdan, J. F. Rossi, Hartmut Goldschmidt, und B. Klein. "Insulin Is a Potent Myeloma Cell Growth Factor Through Insulin/IGF-1 Hybrid Receptor Activation." Leukemia 24, no. 11 (2010). https://doi.org/10.1038/leu.2010.192.
MLA-Zitierstil (9. Ausg.)Sprynski, A. C., et al. "Insulin Is a Potent Myeloma Cell Growth Factor Through Insulin/IGF-1 Hybrid Receptor Activation." Leukemia, vol. 24, no. 11, 2010, https://doi.org/10.1038/leu.2010.192.